Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00707772Phase 4Completed
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Baqiyatallah University of Medical Sciences. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00707772.